dc.contributor.author | Jadhav, Hemant R. | |
dc.date.accessioned | 2024-05-24T09:06:08Z | |
dc.date.available | 2024-05-24T09:06:08Z | |
dc.date.issued | 2023-10 | |
dc.identifier.uri | https://www.eurekaselect.com/article/135622 | |
dc.identifier.uri | http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/14986 | |
dc.description.abstract | Cancer is one of the significant healthcare challenges in today’s world, even after advancements in modern science, including oncology. The complex nature of the disease, which involves multiple proteins and pathways, poses a substantial challenge in drug discovery. Several therapeutic options have emerged in the last decade. Systemic cancer therapies began with the advent of chemotherapy and were revolutionized with the development of targeted therapies. The present review is a definite overview of the advances in various therapeutic options for cancer, with a particular emphasis on targeted therapy using small molecules and biologicals | en_US |
dc.language.iso | en | en_US |
dc.publisher | Bentham Science | en_US |
dc.subject | Pharmacy | en_US |
dc.subject | Anti-cancer therapeutics | en_US |
dc.subject | Targeted therapy | en_US |
dc.subject | Kinase inhibitors | en_US |
dc.subject | Monoclonal antibodies | en_US |
dc.subject | Oncology | en_US |
dc.subject | Cancer treatment | en_US |
dc.title | A Comprehensive Review of Systemic Targeted Therapies in Cancer Treatment | en_US |
dc.type | Article | en_US |
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |